Bifidobacterium adolescentis CCFM1061, fermented food thereof and preparation method of microbial agent
A technology of bifidobacteria and fermented food, applied in bifidobacteria, bacteria used in food preparation, biochemical equipment and methods, etc., can solve the increase of drug toxicity and side effects, liver function damage and edema, adverse reactions of digestive tract, etc. It can reduce the absorption, alleviate the toxicity of PFOA, and improve the antioxidant capacity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Characteristics of Bifidobacterium adolescentis CCFM1061:
[0046] (1) Bacterial characteristics: Gram-positive bacteria that do not form spores and do not move;
[0047] (2) Colony characteristics: After 36 hours of anaerobic culture, obvious colonies are formed, with a diameter between 0.5-1mm, a round front shape, a protruding side shape, neat edges, milky white, translucent, moist and smooth surface, and no pigmentation , see attached figure 1 ;
[0048] (3) Growth characteristics: under the condition of constant temperature and anaerobic at 37° C., cultivate in the modified mMRS medium for about 20 hours to reach the end of logarithmic phase.
[0049] (4) Significantly increase the abundance of Akkermansia in the intestinal tract of NAFLD mice, and reduce the occurrence of diseases such as obesity, diabetic fatty liver and enteritis;
[0050] (5) Significantly improve lipid metabolism disorder in NAFLD mice;
[0051] (6) Significantly improved insulin resistanc...
Embodiment 2
[0099] Example 2: Regulatory effect of Bifidobacterium adolescentis CCFM1061 on intestinal flora of NAFLD mice
[0100] Take 48 healthy male C57BL / 6J mice weighing 16-20g, adapt to the environment for 1 week, and randomly divide them into 6 groups: blank control group (NC), model control group (M), rosiglitazone control group (RC) , simvastatin control group (SC), Bifidobacterium adolescentis CCFM1061 intervention group (CCFM1061), Lactobacillus rhamnosus L10 intervention group (LC), each group contains 8 mice. The experimental animal groups and treatment methods are shown in Table 2:
[0101] Table 2 Grouping of experimental animals
[0102]
[0103]
[0104] At the end of the experiment, the fresh feces of the mice were collected and frozen at -80°C, the metagenome in the feces was extracted, and the structure of the intestinal flora was analyzed using a next-generation sequencer. At the end of the experiment, the mice were fasted for 12 hours, anesthetized by intrap...
Embodiment 3
[0107] Embodiment 3: Bifidobacterium adolescentis CCFM1061 significantly reduces the level of serum total cholesterol (TC) in NAFLD mice
[0108] C57BL / 6J mice grouping, modeling and treatment methods were the same as in Example 2.
[0109] Experimental results such as image 3 shown. The serum total cholesterol content of the mice in the model group was significantly increased, and oral administration of Bifidobacterium adolescentis CCFM1061 significantly reduced the TC level of the model mice and was close to that of the blank control group. Its ability to reduce serum TC in mice was similar to that of the simvastatin drug group.
PUM
Property | Measurement | Unit |
---|---|---|
Thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com